Antiglucocorticoid therapy for the prevention of...

A - Human Necessities – 61 – K

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

A61K 31/235 (2006.01)

Patent

CA 2532415

This invention pertains to the discovery that agents which inhibit the binding of cortisol to its receptors can be used in methods for preventing neurological damage associated with glucocorticoid therapy in ventilator- dependent low birth weight preterm infants. Mifepristone, a potent glucocorticoid receptor antagonist, can be used in these methods.

L'invention concerne la découverte d'agents inhibant la liaison du cortisol à ses récepteurs. Ces agents peuvent être utilisés dans des méthodes de prévention de lésions neurologiques associées à une thérapie glucocorticoïde chez des enfants prématurés présentant un faible poids de naissance et dépendant d'un ventilateur. Le mifepristone, puissant antagoniste du récepteur glucocorticoïde, peut être utilisé dans de telles méthodes.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Antiglucocorticoid therapy for the prevention of... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Antiglucocorticoid therapy for the prevention of..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Antiglucocorticoid therapy for the prevention of... will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1380679

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.